Grading of laboratories on CD4+ T‐lymphocyte evaluations based on acceptable data boundaries defined by the measurement error
- 15 April 2002
- Vol. 50 (2) , 117-126
- https://doi.org/10.1002/cyto.10069
Abstract
BACKGROUND We addressed the definition of limits of error of %CD4+ and CD4+ counts (AbsCD4+) typical of laboratories of excellence, as well as the grading of laboratories based on the decision to take these limits as boundaries of unacceptable data. Methods: We studied the 99.9% confidence intervals of the means of 24 human immunodeficiency virus (HIV)+ and HIV‐ blood samples analyzed by 18 laboratories of the Liguria Region Quality Assessment Program (Liguria Region QALI). Regression equations of lower (L1) and upper (L2) confidence limits over the means of data cleared of unusual results were used to interpolate limits of error for mean values in the tested range. Results: L1 and L2 were symmetric around the mean and a single absolute difference (Abs Res) between the limits and the mean was found. Abs Res significantly increased over mean values (P = 0.0005 for %CD4+, P < 0.0001 for AbsCD4+). Limits were compatible with errors shown with blind replicates. Unacceptable results, outside the limits, accounted for 25% and 30% of %CD4+ and for 18% and 35% AbsCD4+ in the Liguria Region QALI and in the Piemonte Region QA Program, respectively. Limits interpolated over the median showed a similar grading. A comparable fraction of unacceptable data was also found with the method used in the U.K. National External Quality Assessment Scheme (NEQAS) immune monitoring scheme. Conclusions: We propose the general use of these regression equations to determine bounds for unacceptable data in proficiency testing and to identify laboratories of excellence. Cytometry (Clin. Cytometry) 50:117–126, 2002. Published 2002 Wiley‐Liss, Inc.Keywords
This publication has 31 references indexed in Scilit:
- Evaluation of TruCount Absolute-Count Tubes for Determining CD4 and CD8 Cell Numbers in Human Immunodeficiency Virus-Positive AdultsClinical and Diagnostic Laboratory Immunology, 2000
- Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: Results from the UK NEQAS immune monitoring schemeCytometry, 1996
- Initial results of Central European immunophenotyping quality control program (CEQUAL)Cytometry, 1996
- Difficulties in Precise Quantitation of CD4+ T Lymphocytes for Clinical Trials: A ReviewBiologicals, 1993
- Centers for Disease Control Programs in Flow Cytometric ImmunophenotypingAnnals of the New York Academy of Sciences, 1993
- Assessment of the Effects of Instrumentation, Monoclonal Antibody, and Fluorochrome on Flow Cytometric Immunophenotyping: A Report Based on 2 Years of the NIAID DAIDS Flow Cytometry Quality Assessment ProgramClinical Immunology and Immunopathology, 1993
- Department of army lymphocyte immunophenotyping quality assurance programClinical Immunology and Immunopathology, 1989
- Results of the flow cytometry ACTG quality control program: Analysis and findingsClinical Immunology and Immunopathology, 1989
- Immunophenotyping in a multicenter study: The Transfusion Safety Study experienceClinical Immunology and Immunopathology, 1989
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960